Skip to content
- Weight loss drug maker sinks 25% after new safety data spooks investors CNBC
- Boehringer-Zealand’s obesity drug shows promise in cutting visceral, liver fat Reuters
- Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects WSJ
- Nearly 1 in 5 patients quit Boehringer and Zealand’s obesity shot over side effects Endpoints News
- ADA: Boehringer execs claim survodutide tolerability ‘consistent’ with class despite phase 3 update Fierce Biotech